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To date, the Nazarov cyclization of a pentadienone has not been a proven 
methodology towards the construction of the core of the rocaglate natural products. It has 
been found that this conversion can be achieved using acetylbromide in excellent yield. 
This represents the first time acetylbromide has been employed in this manner. This 
methadology provides a very effective and direct route to the core structures of this class 
of molecules. 
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Chapter 1: The Rocaglamide Family of Natural 




 The rocaglamides, isolated from the genus Aglaia, represent a unique group of 
natural products consisting of a cyclopenta[b]tetrahydrobenzofuran skeleton (Figure 
1.1).
1
 This class of natural products derives their name from the parent compound, 





Figure 1.1 Representative members of the rocaglamide family 
 
 
 This class of molecules has received much attention due to their broad range of 
biological activities. Almost all members of this family display potent insecticidal 
activity.
3
 However, greater interest lies in the anti-tumor properties of the rocaglamides.
4 
 2 
In concentrations of 1-10 ng/mL, rocaglamide 1.1.1 has been shown to operate via a 
cytostatic mechanism.
5
 Higher concentrations of 25 ng/mL have been shown to trigger 
apoptosis in leukemia cells.
6
 This activity, combined with a low toxicity towards normal 
cells, makes members of the rocaglamide family promising targets in cancer therapy. 
 
1.2 Previous Syntheses  
 
Due to the biological activity of rocaglamide, as well its interesting structure, 
several research groups have undertaken its total synthesis. Enantioselective syntheses 









 These syntheses tend to suffer from issues of reproducibility, 
formation of the desired cis-aryl geometry, as well as low yielding reactions.   
 
1.2.1 Trost’s Enantioselective Synthesis 
 
Trost reported the first total synthesis of rocaglamide.
7
 This synthesis established 
the absolute stereochemistry of (-)-rocaglamide. The key step of this synthesis was the 
oxidative cyclization of 1.2.1, via an allylic cation, to form the tricyclic core 1.2.2 




Conditions: DDQ, THF, 75% 
Scheme 1.2.1 Formation of tricyclic core 
 
Unfortunately, the approach of the phenolic oxygen was from the same face as the 
phenolic substituent, thus resulting in the undesired trans-aryl geometry.  This meant that 
further steps were needed to establish the desired cis-aryl geometry.  
 
1.2.2 Taylor’s Synthesis 
 
Taylor’s synthesis of rocaglamide is based on the conguate addition of benzofuran 
1.2.3 to E-cinnamaldehyde.
 9
 A pinacolic coupling of 1.2.4 will furnish the tricyclic core 
of rocaglamide (Scheme 1.2.2).  
 
 
Conditions: (a) E-cinnamaldehyde, Triton B, 
t
BuOH, 69%; (b) SmI2, THF, 58%. 
Scheme 1.2.2 Taylor’s formation of the tricyclic core 
 
 4 
Taylor’s synthesis, while shorter than that of Trost, required separation of 
diastereomers to afford the correct stereochemistry in the natural product. Also, the SmI2 
promoted pinacolic coupling was not reproducible. 
 
1.2.3 Porco’s [3+2] Strategy 
 
 Porco’s synthesis was based on the proposed biosynthesis of Proksch.
11
 It was 
proven that exposure of hydroxyflavone 1.2.6 in the presence of methyl cinnamate would 





Conditions: (a) methyl cinnamate, hv (350 nm), MeOH, 1.2.7 (33%) 1.2.8 (17%); (b) NaOMe, 
MeOH, 95%; (c) Me4NBH(OAc)3, MeCN, AcOH, 1.2.10 (51%), 1.2.11 (27%) 
 




However, the photocyclization is neither region- nor stereoselective, requiring the 
separation of multiple products. Following separation of regioisomers, 1.2.7 and 1.2.8 
were treated under basic conditions to induce the alpha-ketol rearrangement to 1.2.9 as a 
mixture of compounds. Templated reduction yielded both trans-diols 1.2.10 and 1.2.11. 
Although this is the shortest route to the rocaglamides, it suffers from a lack of regio- and 
stereo-selectivity, requiring the separation of products at multiple stages.  
 
1.2.4 Frontier’s Synthesis 
 
Frontier’s synthesis involves the construction of ring C using an epoxide-opening 
induced Nazarov cyclization. While this did result in the formation of ring C, it was low 
yielding.
10
 Treatment of 1.2.12 with t-butyl lithium and subsequent trapping of the allenyl 
anion with tri-n-butylin chloride yielded stannyl alkoxyallene 1.2.13. Upon treatment of 
1.2.13 with excess m-CPBA, cyclopentenone 1.2.14 was formed as a single diastereomer. 
This reaction is presumed to proceed via epoxidation of the allenyl ether to give 1.2.15. 
This epoxide can open under acidic conditions to yield the pentadienyl cation 1.2.16 
which will cyclize to 1.2.14 (Scheme 1.2.4). 
 6 
 
Conditions: (a) t-BuLi, BuSnCl, Et2O; (b) m-CPBA, DMF, <40% (over 2 steps) 
Scheme 1.2.4 Peracid initiated Nazarov cyclization 
 
To complete the synthesis, 1.2.14 was treated with DDQ, cleaving the PMB 
group, followed by oxidation of the benzylic position to afford 1.2.17. Palladium 
catalyzed carbonylative conditions yielded methyl ester 1.2.18. Trost’s hydrogenation 
conditions
7
 afforded cyclopentanone 1.2.19 as a single diastereomer. Templated 
reduction, saponification and amide formation completed the synthesis of (±)-
rocaglamide (Scheme 1.2.5).  
 7 
 
Conditions: (a) DDQ, CH2Cl2/H20, 71%; (b) KHMDS, PhNTf2, THF, 83%; (c) Pd(PPH3)4, CO, 
MeOH, iPrEtN, THF (83%); (d) PtO2, H2, EtOH, 65%; (e) NaHB(OAc)3, MeCN/AcOH, 56%; (f) 
LiOH, THF/H2O, 82%; (g) Me2NHHCl, DCC, DMAP, 60%. 
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The synthetic challenges of rocaglamide have been of great interest to the Magnus 
research group over the past several years. In particular, the formation of the desired cis-
aryl geometry was a focal point of research efforts. 
 
2.2 Synthesis of 1,2-anhydro methyl rocaglate 
 
The first methodology explored in the Magnus group centered around whether 
enone 2.2.1 would equilibrate (via beta-hydride elimination), either under acidic or basic 
conditions, to triarylcyclone 2.2.2 (Scheme 2.2.1). If such an equilibrium existed, would 




Scheme 2.2.1 Hypothesized equilibration  
 
In order to test this hypothesis, TIPS enol ether 2.2.3 was constructed and 
subsequently treated with SnCl4 to give the cyclization product 2.2.4 (Scheme 2.2.2). 
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Conditions: (a) SnCl4, CH2Cl2, 50% 
Scheme 2.2.2 Nazarov or Mukaiyama condensation  
 
With enone 2.2.4 in hand, the beta-hydride-elimination hypothesis could be 
tested. Upon exposure of enone 2.2.4 to basic conditions, the deep crimson color 
characteristic of cyclone 2.2.5 was observed (Scheme 2.2.3).  
 
 
Conditions: (a) KOtBu/tBuOH 
 
Scheme 2.2.3 Formation of triarylcyclone  
 
However, cyclization of the phenol oxygens back onto the enone could not be 
induced under a variety of conditions (Scheme 2.2.4). 
 
 
Scheme 2.2.4 Attempt to cyclize 
 
 Unfortunately, the initial hypothesis had been proven incorrect. However, 2.2.4 
was further functionalized to 2.2.5 via hydrosilylation. Desilylation followed by an 
enolate trapping afforded enol triflate 2.2.6. Palladium catalyzed carbonylation of 2.2.6 
 12 
afforded the ester moiety in 2.2.7. Benzylic oxidation to the peroxide, followed by 
reduction, yieled 1,2-anhydro methyl rocaglate 1.2.8 (Scheme 2.2.5).
1
   
 
 
Conditions: (a) Et3SiH, RhCl(PPh3)3, benzene, 88%; (b) BnMe3NF, PhNTf2, 4Å MS, THF, 74%; 
(c) CO (G), Pd(OAc)2, PPh3, Et3N, MeOH, DMF, 82%; (d) t-BuOOH, DARCO, K2CO3, benzene, 
(e) Al(Hg), THF, 36% (2 steps). 
 
Scheme 2.2.5. Formation of 1,2-anhydro methyl rocaglate  
 
 Unfortunately, this synthetic route toward rocaglamide was abandoned as 
sufficient amounts of alcohol 2.2.8 could not be procured.   
 
2.3 Studies of the Nazarov Cyclization 
 
In keeping with the theme of diastereoselective synthesis of ring C, alternative 
routes were explored in the Magnus group. The Nazarov cyclization represents an 
attractive methodology for the formation of the desired cis-aryl geometry. Through 
coordination with either a Lewis or protic acid, a pentadienyl cation can form, which will 
then undergo a 4π-conrotatory
2
 cyclization, forming an allylic cation. This cation, in turn, 







Scheme 2.3.1 Mechanism of Nazarov Cyclization 
 
 
Upon applying the Nazarov cyclization of a dienone to the synthesis of ring C of 
rocaglamide, a model system involving a general dienone 2.3.1 was envisioned, by where 
Lewis acidic conditions could promote a conrotatory electrocyclization (Scheme 2.3.2). 
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Scheme 2.3.2 Nazarov cyclization to form ring C 
 
 
 General dienone 2.3.1 represents an attractive target for cyclization for many 
reasons. First, assuming a proton loss mechanism, two stereocenters are formed 
convergently. Second, the electronics of the cyclization can be tuned using various 
moieties at the -position. Thirdly, the synthesis of a variety of dienones of this nature 
can all be constructed via Horner-Wadsworth-Emmons olefination of the same parent 
benzofuran 2.3.5, which is easily constructed from inexpensive, commercially available 
substrates. Construction of benzo[b]carboxylate 2.3.5 could be constructed via Pd(II)-
catalyzed carbonylative cyclization of phenolic acetylene 2.3.6, which is accessible via 
Kumada coupling of iodophenol 2.3.7 and acetylene 2.3.8 (Scheme 2.3.3). 
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Scheme 2.3.3 Retrosynthesis of  dienone 2.3.1 
 
 Ortho-iodophenol 2.3.7 is prepared in a 7:3 ratio of the undesired para-
iodophenol 2.3.10 from 3,5-dimethoxyphenol (Scheme 2.3.4).
4
 The two major products 
are easily separated using column chromatography. Small amounts of the di-iodophenol 
2.3.11 can subsequently removed via recrystallization. Furthermore, the undesired para-




Scheme 2.3.4. Iodination of 3,5-dimethoxyphenol  
 
  
 Acetylene 2.3.6 can be constructed via Kumada
5
 cross coupling of iodophenol 





Scheme 2.3.5. Kumada cross coupling 
 
 
Subsequently, using Palladium(II)-catalyzed carbonylative cyclization, the desired 
carbonylated benzofuran 2.3.5 can be synthesized. Optimized conditions employing CBr4 




Scheme 2.3.6 Carbonylative cyclization 
 
 
 With parent benzofuran in hand, a series of dienones were constructed. The first 
dienone constructed was the -cyano dienone 2.3.13. Treatment of benzofuran 2.3.6 with 
lithiated acetonitrile formed the -cyano ketone 2.3.12 in 50% yield. Dienone 2.3.13 was 







Scheme 2.3.7. Formation of -cyano dienone 
 
 
 Unfortunately, dienone 2.3.13 was resistant to cyclization under many conditions. 
Weak Lewis acids such as Cu(OTf)2 returned starting material, while harsher conditions, 
including Lewis acids TiCl4, Sc(OTf)3, SnCl4, FeCl3 and protic acids H2SO4 and HCl all 
resulted in intractable mixtures. Correspondence with Alison Frontier at the University of 
Rochester revealed that similar dienones with electron-withdrawing groups at the -
position effectively shut down cyclization.
8
 Thus, a new dienone, one with an -
hydrogen, was envisioned. 
Construction of the -protio dienone was amenable with parent benzofuran. This 
dienone, lacking the electron-withdrawing substituent, was thought to be a better 
substrate for cyclization. In a two step procedure, 2.3.5 was reacted with lithiated 
dimethyl methylphosphonate providing ß-keto phosphonate 2.3.14 in good yield. Horner-






Scheme 2.3.8 Synthesis of -protio dienone 
 
 
 The cyclization of 2.3.15 was screened with many reagents and various 
conditions. Lewis acids, such as AlCl3and Se(OTf)3, resulted in the retro Friedel-Crafts 
product. Protic acids such as H2SO4 and HCl also furnished a retro Friedel-Crafts 
product. Interestingly, treatment of 2.3.15 with HCl in dioxane yielded no reaction.  It 
was conjectured that a delocalized cation was being formed under the reaction conditions 
via the observation of a dark-purple color. If it were possible to stabilize this cation, it 
was hypothesized that one could shift the equilibrium of the pentadienyl cation and the 
allylic cation towards the latter. In order to provide stability of the delocalized cation, an 
-methyl dienone was constructed.  
Treatment of 2.3.5 with lithiated diethyl ethylphosphonate yielded beta-
ketophosphonate 2.3.16 in 90% yield. Horner-Wadsworth-Emmons olefination using 





Scheme 2.3.9 Construction of -methyl dienone  
 
 
Various conditions were screened for the cyclization of -methyl dienone 2.3.17. 
Lewis acids resulted in fragmentation of the molecule in a retro Friedel-Crafts fashion. 





Scheme 2.3.10 Nazarov cyclization of -methyl dienone 
 
This result substantiated the hypothesis that stabilization of the allylic cation 
would lead to formation of ring C. In contrasting this reagent with others tried, it was 
hypothesized that the Lewis-basic oxygens of dioxane could further stabilize the allylic 
cation in an intermolecular fashion. Expanding from this, one could imagine even further 
cation stabilization if there were a Lewis basic neighboring group. Acylation of the 
carbonyl with highly reactive acetly bromide would stabilize the allylic cation through 
 20 
the neighboring group participation of the acetate. Aqueous workup would then furnish 
the desired enone 2.3.18 (Scheme 2.3.11). 
 
Scheme 2.3.11 Hypothesized mechanism of cyclization.  
 
 
Pleasingly, when acetyl bromide was employed, the yield of the reaction 




Scheme 2.3.12 Nazarov cyclization using acetly bromide 
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With the cyclized product obtained in good yield, the further functionalization of 
ring C could be explored. CAN oxidation yielded 2.3.19 in good yield and with the 
proper stereochemistry, as confirmed via X-ray crystallography. Templated reduction of 




Scheme 2.3.13 Further functionalization of ring C 
 
 
Various reagents to oxidize the allylic methyl group were screened on compounds 
2.3.18, 2.3.19 and 2.3.20. Selenium dioxide and Pd(II) conditions tended to return 
starting material. Chromium trioxide/3,5-dimethylpyridine and DDQ conditions 
destroyed the product. Bromination attempts using NBS/AIBN systems resulted in 
undesired aromatic bromination of ring A. Unfortunately, no conditions were found to 
advance these late-stage intermediates to the natural product. It was at this stage in the 
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The formation of the tricyclic core using a novel acetyl bromide initiated Nazarov 
cyclization represented a great advancement in the synthesis of the rocaglamide core. It 
was determined that the continued exploration of this route was deserved of new attention 
and continued research effort. 
 
  
3.2 Exploration of Halogenation 
 
Upon reinvestigation of the problematic oxidation of the allylic methyl group, 
radical halogenation was revisited. Previous research deomstrated that bromination 
occurs first on the A-ring. However, it was hypothesized that once the two aryl positions 
adjacent to the methoxy groups were bromiated, the subsequent bromination would occur 
at the allyilc methyl position, ideally in a one-pot procedure. The inactivated phenyl 
would not be brominated and the ortho positions on the anisol ring would be too 
sterically encumbered by the adjacent phenyl ring. Once a functional handle has been 
installed on the methyl group, subsequent synthetic manipulations could furnish the 
desired moeity and the aryl bromides could be removed via hydrogenation chemistry.  
It was upon reaction of 2.3.19 with a large excess of NBS in CCl4 that the 




Scheme 3.2.1 Dibromination of ring A 
 
 
While isolation of the dibrominated product was not ideal, further bromination of 
3.2.1 could occur upon treatment with NBS in refluxing CCl4 to yield 3.2.2 (Scheme 
3.2.2).  
 




Although the yields were modest with these conditions, and reaction times were 
several days, it was established that the allylic methyl group could be oxidized under 
radical halogenation conditions. New methods of aromatic halogenation were explored, 
resulting in the optimized treatment of 2.3.19 with 1,3-Dibromo-5,5-dimethylhydantoin 




Scheme 3.2.3. Optimized aromatic halogenation  
 
 Furthermore, a simple aqueous workup yielded the desired product in 
spectroscopically pure sample. Optimizing the bromination of the allylic methy group 
was examined next. It was hypothesized that using a high temperature boiling solvent 
would reduce reaction time. The first solvent screened was 1,2-dichlorobenze, with a 
boiling point of 181
o
C, compared to that of CCl4, 77
o
C. 1,2-dichlorobenzene resulted in 
faster consumption of starting material, but yields were modest, due to the possible 
decomposition of starting material. Chlorobenzene, with a boiling point of 
131
o
C,between that of CCl4 and 1,2-dichlorobenzene, was found to be the ideal solvent. 
Clean conversion to 3.2.2 occurred in a matter of hours, and a simple aqueous workup 
resulted in pure sample (Scheme 3.2.4). 
 
 
Scheme 3.2.4 Optimized synthesis of 3.2.2 
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3.3 Further Oxidation Studies  
 
With a scalable and reliable route to 3.2.2, further oxidation methods were 
attempted. Upon exposure of 3.2.2 to Kornblum conditions, aldehyde 3.3.1 and 3.2.2 
were identified via 
1
H-NMR (Scheme 3.3.1).  
 
Scheme 3.3.1 Kornblum Oxidation  
 
Unfortunately, both aldehyde 3.3.1 and 3.3.2 proved to be unstable to flash 
chromatography. It was conjectured that a methyl ether, instead of an aldehyde or an 
alcohol, would be more robust and amenable to isolation and purification. Pleasingly, 
treatment of 3.2.2 with freshly prepared NaOCH3/MeOH solution resulted in clean 
conversion to methyl ester 3.3.3 in excellent yield (Scheme 3.3.2).  
 
Scheme 3.3.2 Conversion to methyl ether 
 
With 3.3.3 in hand, various methods of oxidation were screened for the 
conversion to 3.3.4 (Scheme 3.3.3). 
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Scheme 3.3.3 Attempted oxidation of 3.3.3 
 
 Unfortunately, no adequate conditions were found using Ruthenium based 
systems. Upon further literature investigation, the oxidation of benzylic methyl ethers to 
methyl esters was shown to proceed smoothly using 2 equivalents of NBS.
1
 If only one 
equivalent of NBS was used, the aldehyde was isolated (Scheme 3.3.4). 
 
 
Scheme 3.3.4 Benzylic Oxidation 
 
 Upon treatment of 3.3.3 with 2 equivalents of NBS, methyl ester 3.3.4 was 
observed, as well as aldehyde 3.3.1 (Scheme 3.3.5). 
 29 
 
Scheme 3.3.5 NBS mediated oxidation 
 
 Various other radical halogen sources were screened with a variety of equivalents. 
It was eventually discovered that treatment of 3.3.3 with an excess of trichloroisocyanuric 
acid would result in the exclusive formation of 3.3.4 (Scheme 3.3.6). 
 
 
Scheme 3.3.6 Formation of methyl ester 
 
3.4 Completion of (±)-Methyl Rocaglate  
 
With methyl ester 3.3.4 in hand, various reduction techniques were attempted to 
remove the aryl bromines to form known advanced intermediate 1.2.18 (Scheme 3.4.1).
2  
 
Scheme 3.4.1 Reduction of 3.3.4 
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A series of transition metal hydride sources were attempted. There was 
speculation that too strong of a hydride donor would result in the reduction of the α/β- 
unsaturated ketone or other undesired side reactions. Milder transition metal complexes 
were screened and unfortunately none resulted in the removal of the aromatic bromines. 
This data is summarized in the table below. 
Reagents and Conditions Outcome 
Pd(C), H2(g), EtOH, r.t. no reaction 
Pd(C), H2(g), MeOH, r.t. no reaction 
Pd(C), H2(g), MeOH, 60
oC decomposition 
Raney Nickel, H2(g), MeOH, r.t. no reaction 
Raney Nickel, H2(g), MeOH, 60
oC decomposition 
Zn, NH4HCO3, MeOH, r.t. no reaction 
Zn, NH4HCO3, MeOH, 60
oC decomposition 
Pd(C), (NH2)2HCO3, MeOH, r.t. no reaction 
Pd(C), (NH2)2HCO3, MeOH, 60
oC decomposition 
Table 3.4 Attempts at Reduction  
 
With no leads using this method, it was envisioned that lithium-halogen exchange 
with compound 3.3.4, followed a quench with water, could produce 1.2.18. Treatment of 
3.3.4 with n-butyl lithium resulted in a complex mixture of products. It was believed that 
n-butyl lithium could both displace the ester and well as add into the α/β- unsaturated 
ketone. It was hypothesized that t-butyl lithium, due to its steric bulk, would be less prone 
to addition. Pleasingly, treatment of 3.3.4 with a large excess of t-BuLi resulted in 1.2.18 




Purification via column chromatography completed the synthesis of (±) methyl 
rocaglate.
3
 The concise route to the rocaglamide core, 6 steps in this method, represents a 
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4.1 General Information  
 
Melting points were measured on a Thomas-Hoover capillary tube apparatus and 
are uncorrected.  Infrared spectra were recorded with a Nicolet FT-IR spectrophotometer 
as thin films on a NaCl disc.  
1
H NMR spectra were recorded on a Varian Mercury 400 
MHz instrument as solutions in the indicated solvents and are reported in parts per 
million (ppm) relative to tetramethylsilane and referenced internally to protonated 
residual solvent.  
13
C spectra were recorded at 75 MHz on a General Electric QE-300 
spectrometer as well as on a Varian Inova 500 MHz instrument and a Varian Inova 600 
MHz instrument and are referenced internally to the indicated solvent.  Mass spectra were 
obtained on either a VG ZAB2E or a Finnegan TSQ70 spectrometer using CI. 
 All reactions requiring anhydrous conditions were performed in oven-dried (110
o 
C for >30 min.) or flame-dried glassware under an atmosphere of argon.  Anhydrous 
solvents were distilled under dry nitrogen as follows:  CH2Cl2 and 1,2-DCE from CaH2; 
THF and Et2O from sodium benzophenone ketyl. Reactions were monitored using thin-
layer chromatography on glass-backed plates coated with silica gel containing a 
fluorescent indicator (25 m Silica Gel 60, F254) and were visualized using standard 
techniques: UV fluorescence (254 or 365 nm); phosphomolybdic acid stain.  Flash 
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column chromatography was preformed on silica gel (Kieselgel 60, 40-60 m), with the 
indicated eluent.
 







 Cyclopentenone 2.3.19 (0.86g, 1.93 mmol) was dissolved in wet dioxane (40mL 
dioxane, 8 mL H2O). The flask was cooled to 0 °C and wrapped in aluminum foil. To this 
mixture was added 5,5-Dimethyl-1,3-dibromohydantoin (2.21g, 7.73 mmol). The solution 
was stirred at 0 °C for 2 h at which time the starting material had been consumed. The 
solution was diluted with 50mL H2O and extracted with EtOAc (3 x 50mL). The organic 
layer was washed with H2O (1 x 25mL), brine (1 x 25mL) and subsequently dried 
(MgSO4) and isolated en vacuo to give 20 as light yellow solid (1.09g, 94%). Rf = 0.45 
(30% EtOAc in hexane). Mp. 184-186 °C. IR (thin film) 3300, 2979, 2932, 2868, 1721 
cm-1. 1H NMR (400 MHz, CDCl3)7.40-7.39 (2H, m), 7.34-7.33 (3H, m), 7.25 (2H, d, J= 
8.0 Hz), 6.88 (2H, d, J= 8.8 Hz), 3.96 (3H, s), 3.90 (3H, s), 3.81 (3H, s), 2.08 (3H, s). 13C 
NMR (600 MHz, CDCl3)201.1, 160.7, 159.7, 157.6, 156.6, 155.3, 138.8, 132.4, 129.5, 
129.4, 128.3, 127.6, 125.7, 117.9, 113.9, 105.7, 99.3, 95.8, 86.6, 62.2, 60.8, 55.2, 10.5. 









 To a solution of brominated cyclopentenone 3.2.1 (0.25g, 0.42mmol) and 5,5-
dimethyl-1,3- dibromohydantoin (0.12g, 0.42 mmol) dissolved in chlorobenzene (15mL) 
was added AIBN (3.4 mg, 0.021 mmol). The solution was heated to reflux for 3h. The 
solvent was removed in vacuo to yield a light brown solid. This residue was taken up in 
EtOAc (25 mL) and washed with H2O (3 x 10mL), brine (1 x 10mL) and subsequently 
dried (MgSO4) and evaporated in vacuo to give 21 as light yellow solid (0.27g, 94%). Rf 
= 0.52 (30% EtOAc in hexane). Mp. 176-178 °C. IR (thin film) 3257, 2983, 2936, 1722, 
1514 cm-1. 1H NMR (400 MHz, CDCl3) 7.50-7.38 (5H, m), 7.27 (2H, d, J= 6.8 Hz), 6.91 
(2H, d, J= 8.8 Hz), 4.23 (1H, d, J= 14 Hz), 4.14 (1H, J= 14 Hz), 3.97 (3H, s), 3.91 (3H, 
s), 3.80 (3H, s). 13C NMR (600 MHz, CDCl3) 198.6, 177.5, 163.2, 160.0, 157.8, 156.6, 
155.4, 137.9, 131.2, 130.5, 129.1, 128.7, 127.5, 125.0, 117.4, 114.2, 106.0, 99.0, 95.3, 












 The bromide 3.2.2 (0.27g, 0.39mmol) at room temperature under argon was treated 
with 20mL of freshly prepared 0.1N NaOCH3 in methanol. The reaction was stirred at 
room temperature for an hour at which time the starting material had been consumed. The 
solvent was evaporated in vacuo to yield a light yellow solid. The residue was taken up in 
EtOAc (25 mL) and washed with H2O (3 x 10mL), brine (1 x 10mL) and subsequently 
dried (MgSO4) and evaporated in vacuo to give 22 as light yellow solid (0.24g, 95%). Rf 
= 0.35 (30% EtOAc in hexane). Mp. 160-162 °C. IR (thin film) 3327, 3017, 2940, 1722, 
1593 cm-1. 1H NMR (400 MHz, CDCl3) 7.57-7.55 (2H, m), 7.36-7.34 (3H, m), 7.26 (2H, 
d, J= 8.0 Hz), 6.89 (2H, d, J= 8.8 Hz), 4.26 (1H, d, J= 14.0 Hz),4.16 (1H, d, J= 14 Hz), 
3.94 (3H, s), 3.90 (3H, s), 3.78 (3H, s), 3.40 (3H, s). 13C NMR (600 MHz, CDCl3) 218.1, 
154.5, 153.1,153.0, 152.9, 141.7, 134.0, 116.7, 110.0, 107.2, 106.5, 105.9, 104.0, 103.9, 
103.6, 103.4, 87.5, 87.3, 86.6, 52.4, 52.3, 48.2, 40.2, 32.6. HRMS calculated for 






Methyl Ester 3.2.4 
 
 
 To methyl ether 3.3.3 (56mg, 0.098 mmol) in CCl4 (5 mL) was added 
trichloroisocyanuric acid (65mg, 0.18 mmol). A 50 watt bulb was placed approximately 
10 cm from the flask. The reaction was illuminated for 4 hours at which time the starting 
material had been consumed. Then was added 5mL of 0.1N KOH solution (50% H2O, 
50% acetonitrile) and the reaction was stirred for 15 min. The reaction was diluted with 
15 mL H2O and the aqueous layer was extracted with CH2Cl2 (2 x 15 mL). The organic 
layer was washed with H2O (1 x 15 mL) and brine (1 x 15mL) and dried (MgSO4) and 
evaporated in vacuo to give a light yellow solid. The solid was taken up in EtOAc and 
filtered over a plug of silica to give 23 as a slight yellow solid (43mg, 75%). Rf = 0.30 
(30% EtOAc in hexane). Mp. 155-157 °C. IR (thin film) 3430, 3015, 2940, 2852, 2362, 
1733, 1609 cm-1. 1H NMR (400 MHz, CDCl3) 7.43-7.31 (7H, m) 6.93 (2H, d, J= 9.2 
Hz), 3.94 (3H, s), 3.90 (3H, s), 3.82 (3H, s), 3.80 (3H, s). 13C NMR (600 MHz, CDCl3) 
195.6, 166.1, 163.6, 160.2, 158.0, 156.8, 155.4, 133.4, 131.4, 130.6, 129.6, 128.5, 127.5, 
124.6, 117.2, 114.3, 106.2, 98.8, 95.9, 87.7, 62.4, 60.9, 55.3, 52.8. HRMS calculated for 








 To a solution of methyl ester 3.3.4 (43 mg, 0.067 mmol) in THF at -78 °C was 
added t-butyl lithium (0.4 mL of 1.6M solution in pentane, 0.67 mmol). The reaction was 
stirred at -78 °C for 30 min, at which point the reaction was quenched with 1.0 mL H2O. 
The reaction mixture was diluted with 10mL H2O and the aqueous layer was extracted 
with EtOAc (2 x 10mL). The organic layer was washed with H2O (1 x 10mL) and brine 
(1 x 10mL), dried (MgSO4) and evaporated in vacuo to give a light yellow solid. This 
solid was purified via flash chromatography (10-50% EtOAc/Hexanes) to yield 24 as a 
white solid Mp. 188-192 °C (24 mg, 74%). Rf = 0.09 (30% EtOAc in hexane). 1H NMR 
(400 MHz, CDCl3) 7.43-7.31 (7H, m) 6.93 (2H, d, J= 8.8 Hz), 6.11 (1H, d, J= 2.0 Hz), 
6.06 (1H, d, J= 2.0 Hz) 3.94 (3H, s), 3.90 (3H, s), 3.82 (3H, s), 3.80 (3H, s). 13C NMR 
(600 MHz, CDCl3) 196.3, 165.1, 164.7, 164.2, 161.1, 159.9, 158.5, 132.3, 129.9, 129.8, 
129.5, 128.4, 127.5, 125.5, 114.1, 105.9, 98.7, 92.8, 88.8, 87.0, 55.7, 55.6, 55.2, 52.6. 
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